Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in PRQR — ProQR Therapeutics N.V.

CIK 1214717 BOSTON, MA
Back to PRQR Full portfolio

Position in PRQR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$107,874
-$29,678 QoQ
Shares Held
57,997
-31.7% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 69 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRQR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. PRQR ranks #439 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in PRQR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $107,874 57,997
2026-03-31 $137,552 84,909
2025-12-31 $171,516 84,909
2025-09-30 $103,990 48,822
2025-06-30 $99,596 48,822
2025-03-31 $64,933 48,822
2024-12-31 $129,378 48,822
2024-09-30 $84,941 46,671
2024-06-30 $77,473 46,671
2024-03-31 $106,876 46,671
2023-12-31 $92,408 46,671
2023-09-30 $47,180 36,293
2023-06-30 $58,794 36,293
2023-03-31 $77,304 36,293
2022-12-31 $134,284 36,293
2022-09-30 $27,001 36,293
2022-06-30 $28,235 36,293
2022-03-31 $32,845 36,293
2021-12-31 $290,706 36,293
2021-09-30 $303,772 36,293
2021-06-30 $171,229 25,405
2021-03-31 $129,106 19,532
2020-12-31 $56,212 13,384
2020-09-30 $280,430 58,545
2020-06-30 $336,959 55,421
2020-03-31 $295,971 53,911